Dataset Information

Characterization and proteomic analysis of extracellular vesicles recovered from serum of healthy and dogs naturally infected by Babesia canis

ABSTRACT: Canine babesiosis, a tick-borne disease, is characterized by protozoan parasites invading red blood cells. It is rapidly expanding in many European countries. Examining extracellular vesicles (EVs) and their protein cargo has the potential to offer crucial insights into the response to Babesia canis infection, presenting opportunities for advancements in veterinary diagnostic and therapeutic strategies. In the present study, we have a) isolated small EVs (< 200 nm) from the serum of 15 healthy dogs and 15 dogs naturally infected with B. canis using size-exclusion chromatography (fraction 2 and 3 per each sample), (2) characterized isolated EVs by nanoparticle tracking analysis, transmission electron microscopy and Western blot (3) analysed the protein cargo of isolated EVs by mass spectrometry. We hypothesized that there will be a difference in EV characteristics (size, concentration, EV marker proteins) and profiles of luminal proteins between the two experimental groups. Our aim was to characterize proteins that can offer valuable insights into B. canis infection in dogs, thereby unravelling the complex mechanisms of B. canis infection.

INSTRUMENT(S): Q Exactive HF

ORGANISM(S): Canis Familiaris (dog) (canis Lupus Familiaris)

TISSUE(S): Extracellular Vesicle, Blood Serum

DISEASE(S): Babesiosis

SUBMITTER: Dina Rešetar Maslov

LAB HEAD: Vladimir Mrljak

PROVIDER: PXD047647 | Pride | 2024-04-23

REPOSITORIES: Pride

ACCESS DATA

Similar Datasets

Project description:Background: A fundamental hallmark of cancer cells is their ability to sustain proliferative signaling and cell survival, reflected in a cellular chemotherapy response that is poorly understood. We questioned whether chemotherapy modulated phospho-signaling at 4 and 24 h in vivo could provide information about long-term survival in acute myeloid leukemia (AML), and if the signaling response to therapy was more informative than analysis at time of diagnosis. Methods: Peripheral blood was collected from 32 younger AML patients (age 16-74 years), before, 4- and 24 hours after start of induction chemotherapy. Samples were analyzed by 36-dimensional mass cytometry for assessment of alterations in immunophenotypes and intracellular signaling using unsupervised and supervised machine learning approaches. Results were validated by RNA sequencing and mass spectrometry proteomics (Super SILAC). Targeted sequencing was used to characterize patient samples for recurrent AML mutations. Drug sensitivity and resistance testing ex vivo was compared to activation of relevant signal transduction pathways and mutational profile. Findings: 5-year patient survival was accurately predicted in the leukemic cell population at 24 hours after therapy onset by phospho-proteins p-ERK1/2 (T202/Y204) and p-p38 (T180/Y182). RNA sequencing showed induction of MAPK target gene expression and the AP-1 transcription complex in patients with high p-ERK1/2. Super-SILAC proteomics confirmed an increase in the abundance of p38 prime target MAPKAPK2(MK2) 24 hours after start of induction therapy. Ex vivo drug sensitivity testing demonstrated high sensitivity to MEK inhibitors in the patient cells with high p-ERK1/2 measured at diagnosis or 24 hours after start of chemotherapy. Interpretation: Early single cell signaling response to chemotherapy provided precise prognostic information independent of stratification by genetics. We propose that early functional measurement of chemotherapy-potentiated MAPK pathway signaling could identify non-responders to intensive chemotherapy allowing precise treatment adjustment.

Dataset Information

Characterization and proteomic analysis of extracellular vesicles recovered from serum of healthy and dogs naturally infected by Babesia canis

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure